サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1263898

In Situハイブリダイゼーションの世界市場：動向、機会、競合分析（2023年～2028年）

In Situ Hybridization Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

In Situハイブリダイゼーションの世界市場：動向、機会、競合分析（2023年～2028年）
出版日: 2023年04月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のIn Situハイブリダイゼーションの市場規模は、2028年までに24億米ドルに達し、2023年～2028年にCAGRで9.4%の成長が予測されています。市場の主な促進要因は、遺伝性疾患の流行や、がん治療に対する意識の向上、政府の取り組みの活発化です。

当レポートでは、世界のIn Situハイブリダイゼーション市場について調査分析し、動向と予測、成長機会の分析、企業プロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のIn Situハイブリダイゼーション市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析（2017年～2028年）

  • マクロ経済の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界のIn Situハイブリダイゼーション市場の動向（2017年～2022年）と予測（2023年～2028年）
  • 世界のIn Situハイブリダイゼーション市場：技術別
    • 蛍光In Situハイブリダイゼーション（FISH）
    • 発色In Situハイブリダイゼーション（CISH）
  • 世界のIn Situハイブリダイゼーション市場：プローブ別
    • DNA
    • RNA
  • 世界のIn Situハイブリダイゼーション市場：製品別
    • 器具
    • キット、プローブ
    • ソフトウェア
    • サービス
  • 世界のIn Situハイブリダイゼーション市場：用途別
    • がん
    • 細胞遺伝学
    • 発生生物学
    • 感染症
    • その他
  • 世界のIn Situハイブリダイゼーション市場：最終用途産業別
    • 研究、診断研究所
    • CRO
    • 学術機関
    • その他

第4章 市場動向と予測分析：地域別（2017年～2028年）

  • 世界のIn Situハイブリダイゼーション市場：地域別
  • 北米のIn Situハイブリダイゼーション市場
    • 北米のIn Situハイブリダイゼーション市場：技術別
    • 北米のIn Situハイブリダイゼーション市場：最終用途産業別
  • 欧州のIn Situハイブリダイゼーション市場
    • 欧州のIn Situハイブリダイゼーション市場：技術別
    • 欧州のIn Situハイブリダイゼーション市場：最終用途産業別
  • アジア太平洋のIn Situハイブリダイゼーション市場
    • アジア太平洋のIn Situハイブリダイゼーション市場：技術別
    • アジア太平洋のIn Situハイブリダイゼーション市場：最終用途産業別
  • その他の地域のIn Situハイブリダイゼーション市場
    • その他の地域のIn Situハイブリダイゼーション市場：技術別
    • その他の地域のIn Situハイブリダイゼーション市場：最終用途産業別

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 経営の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略の分析

  • 成長機会の分析
    • 世界のIn Situハイブリダイゼーション市場の成長機会：技術別
    • 世界のIn Situハイブリダイゼーション市場の成長機会：プローブ別
    • 世界のIn Situハイブリダイゼーション市場の成長機会：製品別
    • 世界のIn Situハイブリダイゼーション市場の成長機会：用途別
    • 世界のIn Situハイブリダイゼーション市場の成長機会：最終用途別
    • 世界のIn Situハイブリダイゼーション市場の成長機会：地域別
  • 世界のIn Situハイブリダイゼーション市場における新たな動向
  • 戦略の分析
    • 新製品の開発
    • 世界のIn Situハイブリダイゼーション市場の生産能力拡大
    • 世界のIn Situハイブリダイゼーション市場における合併、買収、合弁事業
    • 認定とライセンシング

第7章 主要企業の企業プロファイル

  • Thermo Fisher Scientific
  • Abbott
  • PerkinElmer
  • BioView
  • Agilent Technologies
目次

In Situ Hybridization Market Trends and Forecast

The future of the in situ hybridization market looks promising with opportunities in the research & diagnostic laboratory, CRO, and academic institute end use industries. The global in situ hybridization market is expected to reach an estimated $2.4 billion by 2028 with a CAGR of 9.4% from 2023 to 2028. The major drivers for this market are increasing prevalence of genetic diseases, rising awareness towards cancer therapeutics, and growing government initiatives.

In Situ Hybridization Market by Technology, Probe, Product, Application, End Use Industry, and Region

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

In Situ Hybridization Market by Segments

In Situ Hybridization Market by Segment

The study includes trends and forecast for the global in situ hybridization market by technology, probe, product, application, end use industry, and region, as follows:

In Situ Hybridization Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:

Fluorescent In Situ Hybridization (FISH)

Chromogenic In Situ Hybridization (CISH)

In Situ Hybridization Market by Probe [Value ($B) Shipment Analysis from 2017 to 2028]:

DNA

RNA

In Situ Hybridization Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

Instruments

Kits & Probes

Software

Services

In Situ Hybridization Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

Cancer

Cytogenetics

Developmental Biology

Infectious Diseases

Others

In Situ Hybridization Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

Research & Diagnostic Laboratories

CROs

Academic Institutes

Others

In Situ Hybridization Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

North America

Europe

Asia Pacific

The Rest of the World

List of In Situ Hybridization Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, in-situ hybridization companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-situ hybridization companies profiled in this report include-

Thermo Fisher Scientific

Abbott

PerkinElmer

BioView

Agilent Technologies

In Situ Hybridization Market Insights

Lucintel forecasts that FISH will remain the larger technology segment over the forecast period because it provides researchers with a method to visualize and map the genetic components in a single cell.

Research & diagnostic laboratories are expected to remain the largest segment due to the rising requirement for rapid & accurate diagnostic techniques.

North America will remain the largest region due to availability of technologically upgraded infrastructure, increasing prevalence of infectious diseases, and growing demand for early diagnosis of diseases in the region.

Features of the In Situ Hybridization Market

Market Size Estimates: In situ hybridization market size estimation in terms of value ($B)

Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.

Segmentation Analysis: In situ hybridization market size by various segments, such as technology, probe, product, application, end use industry, and region

Regional Analysis: In situ hybridization market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.

Growth Opportunities: Analysis on growth opportunities in different technology, probes, products, applications, end use industries, and regions for the in situ hybridization market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape for the in situ hybridization market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the in situ hybridization market size?

Answer: The global in situ hybridization market is expected to reach an estimated $2.4 billion by 2028.

Q2. What is the growth forecast for in situ hybridization market?

Answer: The global in situ hybridization market is expected to grow with a CAGR of 9.4% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the in situ hybridization market?

Answer: The major drivers for this market are increasing prevalence of genetic diseases, rising awareness towards cancer therapeutics, and growing government initiatives.

Q4. What are the major segments for in situ hybridization market?

Answer: The future of the in situ hybridization market looks promising with opportunities in the research & diagnostic laboratory, CRO, and academic institute end use industry.

Q5. Who are the key in situ hybridization companies?

Answer: Some of the key in situ hybridization companies are as follows:

Thermo Fisher Scientific

Abbott

PerkinElmer

BioView

Agilent Technologies

Q6. Which in situ hybridization segment will be the largest in future?

Answer: Lucintel forecasts that FISH will remain the larger technology segment over the forecast period because it provides researchers with a method to visualise and map the genetic components in a single cell.

Q7. In in situ hybridization market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to availability of technologically upgraded infrastructure, increasing prevalence of infectious diseases, and growing demand for early diagnosis of diseases in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1. What are some of the most promising, high-growth opportunities for the in situ hybridization market by technology (fluorescent in situ hybridization (FISH) and chromogenic in situ hybridization (CISH)), probe (DNA and RNA), product (instruments, kits & probes, software, and services), application (cancer, cytogenetics, developmental biology, infectious diseases, and others), end use industry (research & diagnostic laboratories, CROs, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global In Situ Hybridization Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global In Situ Hybridization Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global In Situ Hybridization Market by Technology
    • 3.3.1: Fluorescent In Situ Hybridization (FISH)
    • 3.3.2: Chromogenic In Situ Hybridization (CISH)
  • 3.4: Global In Situ Hybridization Market by Probe
    • 3.4.1: DNA
    • 3.4.2: RNA
  • 3.5: Global In Situ Hybridization Market by Product
    • 3.5.1: Instruments
    • 3.5.2: Kits & Probes
    • 3.5.3: Software
    • 3.5.4: Services
  • 3.6: Global In Situ Hybridization Market by Application
    • 3.6.1: Cancer
    • 3.6.2: Cytogenetics
    • 3.6.3: Developmental Biology
    • 3.6.4: Infectious Diseases
    • 3.6.5: Others
  • 3.7: Global In Situ Hybridization Market by End Use Industry
    • 3.7.1: Research & Diagnostic Laboratories
    • 3.7.2: CROs
    • 3.7.3: Academic Institutes
    • 3.7.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global In Situ Hybridization Market by Region
  • 4.2: North American In Situ Hybridization Market
    • 4.2.1: North American In Situ Hybridization Market by Technology: Fluorescent In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
    • 4.2.2: North American In Situ Hybridization Market by End Use Industry: Research & Diagnostic Laboratories, CROs, Academic Institutes, and Others
  • 4.3: European In Situ Hybridization Market
    • 4.3.1: European In Situ Hybridization Market by Technology: Fluorescent In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
    • 4.3.2: European In Situ Hybridization Market by End Use Industry: Research & Diagnostic Laboratories, CROs, Academic Institutes, and Others
  • 4.4: APAC In Situ Hybridization Market
    • 4.4.1: APAC In Situ Hybridization Market by Technology: Fluorescent In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
    • 4.4.2: APAC In Situ Hybridization Market by End Use Industry: Research & Diagnostic Laboratories, CROs, Academic Institutes, and Others
  • 4.5: ROW In Situ Hybridization Market
    • 4.5.1: ROW In Situ Hybridization Market by Technology: Fluorescent In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH)
    • 4.5.2: ROW In Situ Hybridization Market by End Use Industry: Research & Diagnostic Laboratories, CROs, Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the In Global Situ Hybridization Market by Technology
    • 6.1.2: Growth Opportunities for the In Global Situ Hybridization Market by Probe
    • 6.1.3: Growth Opportunities for the In Global Situ Hybridization Market by Product
    • 6.1.4: Growth Opportunities for the In Global Situ Hybridization Market by Application
    • 6.1.5: Growth Opportunities for the In Global Situ Hybridization Market End Use Industry
    • 6.1.6: Growth Opportunities for the In Global Situ Hybridization Market by Region
  • 6.2: Emerging Trends in the Global In Situ Hybridization Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global In Situ Hybridization Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In Situ Hybridization Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Abbott
  • 7.3: PerkinElmer
  • 7.4: BioView
  • 7.5: Agilent Technologies